Shanghai Raas Blood Products Co., Ltd. It specializes in the research, development, production, and sale of blood and plasma products. The company was established in 1988 and is headquartered in Shanghai, China.

Shanghai Raas Blood Products offers a wide range of high-quality products and services. Its main products include plasma derivatives such as human albumin, immunoglobulin, coagulation factors, and other blood-related products. These products are used in the treatment of various medical conditions, including immunodeficiency disorders, hemophilia, and other blood-related diseases.

On a global scale, Shanghai Raas Blood Products has a strong presence. The company has established several subsidiaries, joint ventures, and partnerships to expand its operations and reach a wider market. It has established joint ventures with international companies such as Grifols, a global leader in the plasma industry, to collaborate on plasma fractionation and plasma collection centers.

Shanghai Raas Blood Products has achieved significant success and made notable achievements in recent years. The company has consistently experienced strong growth in revenue and market share. In terms of global sales, it has emerged as one of the key players in the blood products industry.

The company has invested heavily in research and development to develop innovative products and strengthen its market position. It has also expanded its global footprint through strategic partnerships and collaborations. The company's success can be attributed to its commitment to quality, innovation, and customer satisfaction.

Shanghai Raas Blood Products has implemented rigorous quality control measures to ensure the safety and efficacy of its products. It has also been actively engaged in research and development to meet the evolving needs of patients and healthcare professionals. As of the latest updates, Shanghai Raas Blood Products is in a strong financial position and continues to expand its global presence.

The company is well-positioned to seize growth opportunities in the global blood products market and further enhance its market share. It remains dedicated to its mission of improving the quality of life for patients worldwide by providing safe and effective blood products. Overall, Shanghai Raas Blood Products is a leading biopharmaceutical company with a strong presence in the global market.

With its wide range of blood and plasma products, strategic partnerships, and commitment to innovation, the company continues to make significant contributions to the healthcare industry